News
Low-Risk DCIS Research Update and Resources by PRECISION Patient Advocates
Feb 2, 2023
The PRECISION team is proud to share a document prepared by our wonderful team of Patient Advocates on the latest research and resources updates on Low-risk DCIS. The purpose of this document is to provide most up-to-date information about DCIS and its current...
read moreChallenging the current dogma: DCIS – a precursor lesion, a risk lesion or both for subsequent invasive breast cancer?
Jun 9, 2022
Women with DCIS may develop invasive breast cancer in the same breast despite treatment. To study whether DCIS is the true precursor of all subsequent ipsilateral invasive breast cancer, PRECISION scientists compared the genetic changes in women with an initial DCIS...
read morePRECISION researcher wins prestigious Veni Grant awarded by the Dutch Research Council (NWO)
Nov 9, 2020
Hendrik Messal, post doc in the lab of PRECISION Co-Investigator Jacco van Rheenen, has been awarded the prestigious Veni grant by the Dutch Research Council. He has been recognised for developing 3D whole organ microscopy with which he plans to investigate how...
read moreCan invasive treatment be avoided for patients diagnosed with DCIS?
Oct 27, 2020
Read an interview by CURE magazine featuring PRECISION’s patient advocate Donna Pinto and Co-Investigator Prof. Dr. Alastair Thompson. When patients with the earliest forms of breast cancer may be able to skip surgery
read morePRECISION launches a Series of Plain Language Summaries
Oct 27, 2020
The PRECISION patient advocates have launched a new and effective style of communicating our research to a wider audience including the public, policy makers and other relevant stakeholders. Read the plain language summary of the scientific publications and explore...
read morePRECISION publishes its second newsletter
Aug 14, 2020
Read the newsletter by clicking on the link below https://www.dcisprecision.org/wp-content/uploads/2020/08/DCIS-Nieuwsbrief-Final_140820.pdf
read more5th World Congress on Controversies in Breast Cancer (CoBrCa 2019, San Francisco)
Oct 10, 2019
PRECISION patient advocates Donna Pinto and Deborah Collyar attended the 5th World Congress on Controversies in Breast Cancer, CoBrCa 2019 in San Francisco from 4th-6th Sep which was co-organized by Prof. Alastair Thompson. Donna chaired debate sessions - "That most...
read more2nd PRECISION Annual Meeting 13-14 June 2019
Sep 18, 2019
The whole team gathered for the 2nd Annual PRECISION meeting at The Netherlands Cancer Institute (NKI) in Amsterdam from 11th -12th June 2019. The two day program consisted of talks and poster session by junior researchers, patient advocates and work package leaders...
read moreFeiten en Vragen LORD studie
Sep 18, 2019
The Dutch Patient Advocates: Marja van Oirsouw and Ellen Verschuur put together a flyer with information about DCIS and the LORD clinical trial. https://www.dcisprecision.org/wp-content/uploads/2019/09/Feiten-en-vragen-LORD-studie-aangepast.pdf *This information is...
read morePRECISION publishes it’s first newsletter
Aug 7, 2019
Read the newsletter by clicking on the link below https://www.dcisprecision.org/wp-content/uploads/2019/08/Final-Newsletter_11th-June-2019.pdf
read more